Caxton Associates LP Perkinelmer Inc Transaction History

Caxton Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.0 - $137.11 $0 - $536,374	3,912 New	3,912 $0
Q4 2021 Feb 14, 2022	SELL	$166.66 - $201.06 $540,811 - $652,439	-3,245 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$127.81 - $155.84 $414,743 - $505,700	3,245 New	3,245 $501,000
Q4 2020 Feb 16, 2021	SELL	$122.05 - $147.91 $802,234 - $972,212	-6,573 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$97.09 - $125.51 $638,172 - $824,977	6,573 New	6,573 $825,000
Q4 2019 Feb 14, 2020	SELL	$79.1 - $97.45 $210,959 - $259,899	-2,667 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$79.44 - $98.79 $211,866 - $263,472	2,667 New	2,667 $227,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.